Gene · 634
Papers3,222
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
781 to 800 of 3,222
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Randomized Crossover Trial Evaluating Detoxification of Tobacco Carcinogens by Broccoli Seed and Sprout Extract in Current Smokers. | Cancers (Basel) | 2022 | 35565256 | PubTator, text mining | PubMed |
| Risk Factors and Biomarkers for Immune-Related Adverse Events: A Practical Guide to Identifying High-Risk Patients and Rechallenging Immune Checkpoint Inhibitors. | Front Immunol | 2022 | 35558065 | PubTator, text mining | PubMed |
| Structural Basis for Allostery in PLP-dependent Enzymes. | Front Mol Biosci | 2022 | 35547395 | PubTator, text mining | PubMed |
| New insights into checkpoint inhibitor immunotherapy and its combined therapies in hepatocellular carcinoma: from mechanisms to clinical trials. | Int J Biol Sci | 2022 | 35541908 | PubTator, text mining | PubMed |
| Immunological Changes in Pregnancy and Prospects of Therapeutic Pla-Xosomes in Adverse Pregnancy Outcomes. | Front Pharmacol | 2022 | 35517798 | PubTator, text mining | PubMed |
| The Basis and Advances in Clinical Application of Cytomegalovirus-Specific Cytotoxic T Cell Immunotherapy for Glioblastoma Multiforme. | Front Oncol | 2022 | 35515137 | PubTator, text mining | PubMed |
| Cardiac Remodeling After Myocardial Infarction: Functional Contribution of microRNAs to Inflammation and Fibrosis. | Front Cardiovasc Med | 2022 | 35498051 | PubTator, text mining | PubMed |
| Betacellulin promotes tumor development and EGFR mutant lung cancer growth by stimulating the EGFR pathway and suppressing apoptosis. | iScience | 2022 | 35494243 | PubTator, text mining | PubMed |
| TIM-3 Expression Level on AML Blasts Correlates With Presence of Core Binding Factor Translocations Rather Than Clinical Outcomes. | Front Oncol | 2022 | 35494006 | PubTator, text mining | PubMed |
| AFF3 is a novel prognostic biomarker and a potential target for immunotherapy in gastric cancer. | J Clin Lab Anal | 2022 | 35478418 | PubTator, text mining | PubMed |
| Human placental proteomics and exon variant studies link AAT/SERPINA1 with spontaneous preterm birth. | BMC Med | 2022 | 35477570 | PubTator, text mining | PubMed |
| Alkaline Phosphatase Activity of Serum Affects Osteogenic Differentiation Cultures. | ACS Omega | 2022 | 35474849 | PubTator, text mining | PubMed |
| Placental dysfunction influences fetal monocyte subpopulation gene expression in preterm birth. | JCI Insight | 2022 | 35471950 | PubTator, text mining | PubMed |
| Tim-3 Expression Causes NK Cell Dysfunction in Type 2 Diabetes Patients. | Front Immunol | 2022 | 35464400 | PubTator, text mining | PubMed |
| Design and Evaluation of TIM-3-CD28 Checkpoint Fusion Proteins to Improve Anti-CD19 CAR T-Cell Function. | Front Immunol | 2022 | 35464394 | PubTator, text mining | PubMed |
| A systemic review of the role of enterotoxic Bacteroides fragilis in colorectal cancer. | Neoplasia | 2022 | 35461079 | PubTator, text mining | PubMed |
| Is There a Role for Gut Microbiome Dysbiosis in IgA Nephropathy? | Microorganisms | 2022 | 35456735 | PubTator, text mining | PubMed |
| Transcriptional Profiling and Deriving a Seven-Gene Signature That Discriminates Active and Latent Tuberculosis: An Integrative Bioinformatics Approach. | Genes (Basel) | 2022 | 35456421 | PubTator, text mining | PubMed |
| Clinical Applications of Classical and Novel Biological Markers of Pancreatic Cancer. | Cancers (Basel) | 2022 | 35454771 | PubTator, text mining | PubMed |
| Serum Level of CEACAM1 in Patients with Nonsmall Cell Lung Cancer and Its Clinical Significance in Cancer Tissue. | J Healthc Eng | 2022 | 35449849 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/634/papers?page=40